Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 171 (Search time: 0.005 seconds).
previous
1
2
3
4
...
18
next
Item hits:
Preview
Issue Date
Title
Author(s)
2016
ABCB1 overexpression predicts outcome of CML patients undergoing first-line imatinib treatment
Eadie, L.
;
Hughes, T.
;
White, D.
;
New Directions in Leukaemia Research 2016 Meeting (NDLR) (16 Mar 2016 - 19 Mar 2016 : Noosa, QLD)
1997
Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
Lewis, I.
;
Haylock, D.
;
Moore, S.
;
To, L.
;
Hughes, T.
1998
Stem cell factor as a single agent induces marked proliferation of the philadelphia chromosome positive fraction of CML CD34+ cell
Moore, S.
;
Haylock, D.
;
Levesque, J.P.
;
McDiarmid, L.
;
Samels, L.
;
To, L.
;
Simmons, P.
;
Hughes, T.
2008
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
Hughes, T.
2014
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint
Branford, S.
;
Ross, D.
;
Yeung, D.
;
Braley, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2004
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
Szer, J.
;
Durrant, S.
;
Schwarer, A.
;
Bradstock, K.
;
Gibson, J.
;
Arthur, C.
;
To, L.
;
Hughes, T.
;
Raunow, H.
2004
Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
Mollee, P.
;
Arthur, C.
;
Hughes, T.
;
Januszewicz, H.
;
Grigg, A.
;
Bradstock, K.
;
Wolf, M.
;
Gibson, J.
;
Schwarer, A.
;
Spencer, A.
;
Browett, P.
;
Hawkins, T.
;
Seldon, M.
;
Herrmann, R.
;
Watson, A.
;
Seymour, J.
;
Martin, N.
;
Shina, S.
;
Low, C.
;
Wright, S.
;
et al.
2013
STAT5 is a critical component of the time-dependent sensitivity of CML cells to TKI treatment in a BCR-ABL-dependent, but JAK2-independent manner
Schafranek, L.
;
Nievergall, E.
;
Powell, J.
;
Hiwase, D.
;
White, D.
;
Hughes, T.
;
Leclercq, T.
2000
A new rare t(9;11)(p22;p15) in acute leukaemia
Nicola, M.
;
Suttle, J.
;
Beerworth, J.
;
Dobrovic, A.
;
Hughes, T.
;
Moore, S.
2010
Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial
Yeung, D.
;
Osborn, M.
;
White, D.
;
Branford, S.
;
Haswell, L.
;
Slader, C.
;
Issa, S.
;
Hiwase, D.
;
Hertzberg, M.
;
Schwarer, A.
;
Filshie, R.
;
Arthur, C.
;
Kwan, Y.
;
Forsyth, C.
;
Ross, D.
;
Mills, A.
;
Grigg, A.
;
Hughes, T.
;
Annual Meeting of the American Society of Hematology (52nd : 2010 : Orlando, Fl.)
Discover
Author
61
Branford, S.
53
White, D.
35
Hochhaus, A.
22
Kantarjian, H.
22
Radich, J.
22
Saglio, G.
20
Kim, D.
20
Yeung, D.
19
Ross, D.
17
Cortes, J.
.
next >
Subject
90
Humans
65
Pyrimidines
64
Leukemia, Myelogenous, Chronic, B...
55
Piperazines
54
Benzamides
52
Imatinib Mesylate
42
Antineoplastic Agents
40
Fusion Proteins, bcr-abl
38
Protein Kinase Inhibitors
31
Male
.
next >
Date issued
1
2020 - 2022
97
2010 - 2019
64
2000 - 2009
9
1995 - 1999